US2358511028 - Common Stock
219.88 +0.44 (+0.2%)
NYSE:DHR (12/6/2023, 11:25:05 AM)
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 79,000 full-time employees. The Company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Life Sciences segment offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs, and vaccines. Its Diagnostics segment offers clinical instruments, reagents, consumables, software that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease.
2200 Pennsylvania Ave NW Ste 800W
WASHINGTON WASHINGTON DC 20037
CEO: Rainer M. Blair
/PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The...
Danaher (DHR) declares $0.24/share quarterly dividend, -11.1% decrease from prior dividend of $0.27. Forward yield 0.44% Payable Jan. 26; for shareholders of re
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.24 per share...
Investors wanting big gains should consider these companies, each of which has a stock that has outperformed the market over the last year.
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI...
Here you can normally see the latest stock twits on DHR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.